🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03280X102
- Market Cap
- Micro Cap · $33 Million
- IPO
- 2/12/2019 · $11.50/share
- ADR Ratio
- 1:5
Business: Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, with offices in Cambridge, MA, and Jerusalem, Israel.
Company Contact
- CEO
- Neil Cohen
- CFO
- Andrew Fine
- Headquarters
- One Kendall Square, Building 1400E, Suite 14-105, Cambridge, MA 02139
- Phone
- 857-259-4622
- Investor Relations
- 857-259-4622 · info@anchiano.com